XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Jan. 31, 2022
Jul. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 65,025 $ 7,854
Restricted cash 5,000 5,000
Trade accounts receivable, net of allowance for doubtful accounts of $230 and $193 at January 31, 2022 and July 31, 2021, respectively 616 235
Due from Rafael Pharmaceuticals, net of allowance for losses on related party receivables of $720 and $0 at January 31, 2022 and July 31, 2021, respectively 600
Prepaid expenses and other current assets 903 1,075
Total current assets 71,544 14,764
Property and equipment, net 42,537 43,238
Equity investment – RP Finance LLC 575
Due from RP Finance LLC, net of allowance for losses on related party receivables of $9,375 and $0 at January 31, 2022 and July 31, 2021, respectively 7,500
Investments – Rafael Pharmaceuticals 79,141
Investments – Other Pharmaceuticals 477 477
Investments – Hedge Funds 5,025 5,268
In-process research and development and patents 1,575 1,575
Other assets 1,410 1,517
TOTAL ASSETS 122,568 154,055
CURRENT LIABILITIES    
Trade accounts payable 1,125 1,160
Accrued expenses 6,622 1,227
Other current liabilities 246 252
Due to related parties 57 136
Note payable, net of debt issuance costs 14,778 14,528
Total current liabilities 22,828 17,303
Other liabilities 84 48
TOTAL LIABILITIES 22,912 17,351
COMMITMENTS AND CONTINGENCIES  
EQUITY    
Class A common stock, $0.01 par value; 35,000,000 shares authorized, 787,163 shares issued and outstanding as of January 31, 2022 and July 31, 2021, respectively 8 8
Class B common stock, $0.01 par value; 200,000,000 shares authorized, 19,051,500 issued and 19,029,012 outstanding as of January 31, 2022, and 16,947,066 issued and 16,936,864 outstanding as of July 31, 2021 190 169
Additional paid-in capital 253,896 159,136
Accumulated deficit (155,144) (40,799)
Accumulated other comprehensive income related to foreign currency translation adjustment 3,927 3,772
Total equity attributable to Rafael Holdings, Inc. 102,877 122,286
Noncontrolling interests (3,221) 14,418
TOTAL EQUITY 99,656 136,704
TOTAL LIABILITIES AND EQUITY $ 122,568 $ 154,055